A little news from one of my other holdings:
" Oramed Pharmaceuticals Inc. (ORMP.ob), a developer of oral delivery systems, today reported that its wholly owned Israeli subsidiary, Oramed Ltd., was awarded a government grant
amounting to a total net amount of NIS 3.1 million ($828,000),
from the Office of the Chief Scientist (OCS) at the Ministry of Industry, Trade and Labor of Israel... The OCS awards grants to industry in Israel in order to foster technological innovations. The funds will be designated and used by Oramed Ltd. to support further R&D and clinical study of its Oral Insulin capsule and Oral GLP1-Analog... "
